おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
GelTex Pharmaceuticals
company
About
GelTex Pharmaceuticals develops and markets non-absorbed polymer drugs.
- 1 - 10
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $6.80M
- Industries
- Biotechnology,Health Care
- Founded date
- Jan 1, 1992
- Number Of Employee
- 1 - 10
- Operating Status
- Active
GelTex Pharmaceuticals develops and markets non-absorbed polymer drugs that bind and eliminate targeted substances within the gastrointestinal tract. It also develops small-molecule pharmaceuticals consisting of novel polyamine analogues and metal chelators. Its focus areas include hyperphosphatemia, hypercholesterolemia, cancer, iron overload, and infectious diseases.GelTex Pharmaceutics is based in Waltham Massachusetts.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$6.80M
GelTex Pharmaceuticals has raised a total of
$6.80M
in funding over 2 rounds. Their latest funding was raised on
Sep 9, 1993 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 9, 1993 | Series Unknown | $6.80M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
GelTex Pharmaceuticals is funded by 2 investors.
Norwest Venture Partners
and Biotechnology Investments
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Norwest Venture Partners
|
— | Series Unknown |
|
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
